Adelar Lofungola
Research Subjects
Adelar Lofungola has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Adrienne Amuri-Aziza
Institut National de Recherche Biomédicale
2 shared publications - Aine O'Toole
Institute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK
2 shared publications - Andrew Rambaut
Institute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK
2 shared publications - Anne W. Rimoin
Department of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, CA, USA
2 shared publications - Christian Ngandu
National Institute of Public Health, Democratic Republic of the Congo
2 shared publications - Cris Kacita
Institut National de Santé Publique (INSP), Kinshasa P.O. Box 3088, Democratic Republic of the Congo
2 shared publications
Latest Publications
- Open Access
Mpox Clade IIb Virus Introduction into Kinshasa, Democratic Republic of the Congo, July 2025
Clade I mpox virus (MPXV) is endemic in the Democratic Republic of the Congo (DRC). Recent studies have described the changing epidemiology of mpox in the country, which has been mainly characterized by the emergence of new MPXV lineages, Clade Ib/sh2023 and Ia/sh2024, associated with sustained human-to-human transmission. Both Clade Ib/sh2023 and Ia/sh2024 are co-circulating in Kinshasa, the capital city of the DRC. Here, we report the first two cases of Clade IIb/sh2017 identified in Kinshasa, DRC, imported from West Africa and locally transmitted. Clinical specimens were collected and tested by PCR. We performed whole genome sequencing using a tiled-amplicon sequencing approach with Clade IIb MPXV-specific primers. The phylogenetic tree shows that Kinshasa Clade IIb MPXV is assigned to Clade IIb/sh2017 within the newly designated lineage G.1, as identified in January 2025 in Sierra-Leone.
Open AccessMpox Clade IIb Virus Introduction into Kinshasa, Democratic Republic of the Congo, July 2025
Clade I mpox virus (MPXV) is endemic in the Democratic Republic of the Congo (DRC). Recent studies have described the changing epidemiology of mpox in the country, which has been mainly characterized by the emergence of new MPXV lineages, Clade Ib/sh2023 and Ia/sh2024, associated with sustained human-to-human transmission. Both Clade Ib/sh2023 and Ia/sh2024 are co-circulating in Kinshasa, the capital city of the DRC. Here, we report the first two cases of Clade IIb/sh2017 identified in Kinshasa, DRC, imported from West Africa and locally transmitted. Clinical specimens were collected and tested by PCR. We performed whole genome sequencing using a tiled-amplicon sequencing approach with Clade IIb MPXV-specific primers. The phylogenetic tree shows that Kinshasa Clade IIb MPXV is assigned to Clade IIb/sh2017 within the newly designated lineage G.1, as identified in January 2025 in Sierra-Leone.
- Open Access
- 25 November 2025
- Published by MDPI AG in Preprints.org
Mpox Clade IIb Virus Introduction into Kinshasa, Democratic Republic of the Congo, July 2025
Mpox virus lineages associated with sustained human-to-human transmission, Clade Ib/sh2023 and Ia/sh2024, are co-circulating in Kinshasa, Democratic Republic of the Congo (DRC). We report the first two Clade IIb/sh2017 cases identified in DRC, imported from West Africa and locally transmitted, with phylogenetic linkage to the ongoing outbreak in Sierra Leone.
- 25 November 2025
- Published by MDPI AG in Preprints.org
Open AccessMpox Clade IIb Virus Introduction into Kinshasa, Democratic Republic of the Congo, July 2025
Mpox virus lineages associated with sustained human-to-human transmission, Clade Ib/sh2023 and Ia/sh2024, are co-circulating in Kinshasa, Democratic Republic of the Congo (DRC). We report the first two Clade IIb/sh2017 cases identified in DRC, imported from West Africa and locally transmitted, with phylogenetic linkage to the ongoing outbreak in Sierra Leone.